James Schaf

  • Citations Per Year
Learn More
Since 1983, when c-DNA was isolated, recombinant tissue plasminogen activator (rtPA), an endothelial-cell-produced activator of fibrinolysis is used, more increasingly often in therapy of thrombosis. Whereas some studies have been published regarding efficacy and safety rtPA in different thrombotic states of adults, only case reports exist in children.(More)
This document serves as supplemental material for the paper “User Preferences for Hybrid Explanations”, by Pigi Kouki, James Schaffer, Jay Pujara, John O’Donovan, and Lise Getoor, published on the 11th ACM Conference on Recommender Systems [1]. In this document, we present the details of the survey presented in the paper, and we encourage the reader to read(More)
  • 1